- Enabled Products
- Enabling Products
Synthetic Biology Market size was valued at USD 9.4 billion in 2022 and is expected to reach USD 47.4 billion by 2029, at a CAGR of 26% during forecast period 2023-29. Synthetic biology is a new interdisciplinary area of the medical field that involves the application of engineering principles in biology. Synthetic biology combines various disciplines within both domains such as genetic engineering, biotechnology, molecular engineering biophysics, computer engineering, electrical engineering and other various branches for the development of artificial biological systems for research engineering and medical applications. The design and building of new biological parts, equipment, and systems, as well as the re-design of existing, natural biological systems for practical purposes, are all examples of synthetic biology. Furthermore, it has various applications in industrial enzymes, vaccines and antibody production, bio-based chemicals as well as synthetic biological life science research. Synthetic biology is an evolutionary segment of medical technology and market is in the developing stage. Market players and researchers are actively participating in R&D activities to develop and introduce the revolutionary technologies. Furthermore, government funding and support for the research fuelling the market growth. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the rising needs of the healthcare industry and fight new ailments. Collaboration and acquisitions are key strategies adopted by the market players to boost their market revenue share in synthetic biology market.
Synthetic Biology Market Key Developments:
- For instance, in March 2015, Synpromics Limited, collaborated with iniQure N.V. to develop synthetic promoters with a specific application in the delivery of gene medicines to the liver.
- In January 2017, Ginkgo Bioworks, a microorganism company acquired a provider of synthetic DNA Gen9. By this acquisition, company seeks to improve its speed and capacity in constructing new organism design for use across the multiple industries
Synthetic Biology Market Summary
Study Period
2023-29
Base Year
2022
CAGR
26%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Synthetic Biology Market Dynamics
Synthetic biology market is driven by the rapid increase in R&D investments in synthetic biology and adaptation of genetically engineered products and DNA sequencing for the treatment and understanding of the diseases progress. In addition, increase in funding from government in life science research and development and advancements in molecular biology expected to boost the synthetic biology during the forecast period. Furthermore, private institutional contribution to synthetic biology research expected to push the market growth. However, lack of regulatory framework, biosafety and biosecurity issues coupled with government policies may hinder the synthetic biology market growth over the forecast period.
hghNorth America Got Significant Share
Synthetic Biology Market Regional Analysis
North America dominates the market region for Synthetic Biology Market. A significant portion can be attributed to rising investment in private businesses, advantageous rules, and government support. In order to fuel the expansion of the synthetic biology business, the U.S. primarily focuses on research in the fields of proteomics, drug screening and discovery, and genomic structure prediction. The synthetic biology market is expected to grow at the fastest rate in the Asia Pacific region, which is expected to be fueled by factors such as rising investments in Asia Pacific nations, expanding partnerships & funding in the Chinese market, and expanding collaborations in the field of synthetic biology.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The synthetic biology market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Synthetic Biology Market Segmentation
By Technology
By Products
- Synthetic DNA
- XNA
- Chassis Organism
By Application
- Chemicals
- Pharmaceuticals
- Biopharmaceuticals
- Agriculture
- Others
LOCATION
Geography
Frequently Asked Questions
The Synthetic Biology Market size was valued at USD 9.4 billion in 2022
Asia Pacific is the fastest-growing for synthetic biology market
The synthetic biology market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Synthetic Biology Market Introduction |
| 2.1. Global Synthetic Biology Market – Taxonomy |
| 2.2. Global Synthetic Biology Market –Definitions |
| 2.2.1. Product Type |
| 2.2.2. Technology |
| 2.2.3. Application |
| 2.2.4. Region |
| 3. Global Synthetic Biology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Current Trends |
| 3.5. Global Synthetic Biology Market Dynamic Factors - Impact Analysis |
| 3.6. Mergers, Acquisitions, and Collaborations |
| 4. Global Synthetic Biology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Synthetic Biology Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Core Products |
| 5.1.1. Synthetic DNA |
| 5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Synthetic Genes |
| 5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.1.3. Synthetic Cells |
| 5.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3.3. Market Opportunity Analysis |
| 5.1.4. Chassis organisms |
| 5.1.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4.3. Market Opportunity Analysis |
| 5.1.5. XNO (Xeno Nucleic Acid) |
| 5.1.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.5.3. Market Opportunity Analysis |
| 5.2. Core Products |
| 5.2.1. DNA Synthesis |
| 5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Oligonucleotide Synthesis |
| 5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 6. Global Synthetic Biology Market, By Technology, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1. Bioinformatics |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Microfluidics |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Genetic Engineering |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. DNA Sequencing |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Nucleotide Synthesis and Sequencing |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Integrated Systems |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Synthetic Biology Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1. Pharmaceuticals & Diagnostics |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Chemicals |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Biofuels |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Bioplastics |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Synthetic Biology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, and Country, 2023 - 2029 |
| 9. North America Synthetic Biology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Core Products |
| 9.1.1.1. Synthetic DNA |
| 9.1.1.2. Synthetic Genes |
| 9.1.1.3. Synthetic Cells |
| 9.1.1.4. Chassis organisms |
| 9.1.1.5. XNO (Xeno Nucleic Acid) |
| 9.1.2. Enabling Products |
| 9.1.2.1. DNA Synthesis |
| 9.1.2.2. Oligonucleotide Synthesis |
| 9.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Bioinformatics |
| 9.2.2. Microfluidics |
| 9.2.3. Genetic Engineering |
| 9.2.4. DNA Sequencing |
| 9.2.5. Nucleotide Synthesis and Sequencing |
| 9.2.6. Integrated Systems |
| 9.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Pharmaceuticals & Diagnostics |
| 9.3.2. Chemicals |
| 9.3.3. Biofuels |
| 9.3.4. Bioplastics |
| 9.3.5. Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. United States |
| 9.4.2. Canada |
| 9.5. North America Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 9.6. North America Synthetic Biology Market Dynamics – Trends |
| 10. Europe Synthetic Biology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Core Products |
| 10.1.1.1. Synthetic DNA |
| 10.1.1.2. Synthetic Genes |
| 10.1.1.3. Synthetic Cells |
| 10.1.1.4. Chassis organisms |
| 10.1.1.5. XNO (Xeno Nucleic Acid) |
| 10.1.2. Enabling Products |
| 10.1.2.1. DNA Synthesis |
| 10.1.2.2. Oligonucleotide Synthesis |
| 10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Bioinformatics |
| 10.2.2. Microfluidics |
| 10.2.3. Genetic Engineering |
| 10.2.4. DNA Sequencing |
| 10.2.5. Nucleotide Synthesis and Sequencing |
| 10.2.6. Integrated Systems |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Pharmaceuticals & Diagnostics |
| 10.3.2. Chemicals |
| 10.3.3. Biofuels |
| 10.3.4. Bioplastics |
| 10.3.5. Others |
| 10.4. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. UK |
| 10.4.2. Germany |
| 10.4.3. France |
| 10.4.4. Italy |
| 10.4.5. Spain |
| 10.4.6. Rest of Europe |
| 10.5. Europe Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 10.6. Europe Synthetic Biology Market Dynamics – Trends |
| 11. Asia Pacific Synthetic Biology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Core Products |
| 11.1.1.1. Synthetic DNA |
| 11.1.1.2. Synthetic Genes |
| 11.1.1.3. Synthetic Cells |
| 11.1.1.4. Chassis organisms |
| 11.1.1.5. XNO (Xeno Nucleic Acid) |
| 11.1.2. Enabling Products |
| 11.1.2.1. DNA Synthesis |
| 11.1.2.2. Oligonucleotide Synthesis |
| 11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Bioinformatics |
| 11.2.2. Microfluidics |
| 11.2.3. Genetic Engineering |
| 11.2.4. DNA Sequencing |
| 11.2.5. Nucleotide Synthesis and Sequencing |
| 11.2.6. Integrated Systems |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Pharmaceuticals & Diagnostics |
| 11.3.2. Chemicals |
| 11.3.3. Biofuels |
| 11.3.4. Bioplastics |
| 11.3.5. Others |
| 11.4. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. China |
| 11.4.2. India |
| 11.4.3. ANZ |
| 11.4.4. Japan |
| 11.4.5. Rest of APAC |
| 11.5. Asia Pacific Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 11.6. Asia Pacific Synthetic Biology Market Dynamics – Trends |
| 12. MEA Synthetic Biology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Core Products |
| 12.1.1.1. Synthetic DNA |
| 12.1.1.2. Synthetic Genes |
| 12.1.1.3. Synthetic Cells |
| 12.1.1.4. Chassis organisms |
| 12.1.1.5. XNO (Xeno Nucleic Acid) |
| 12.1.2. Enabling Products |
| 12.1.2.1. DNA Synthesis |
| 12.1.2.2. Oligonucleotide Synthesis |
| 12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Bioinformatics |
| 12.2.2. Microfluidics |
| 12.2.3. Genetic Engineering |
| 12.2.4. DNA Sequencing |
| 12.2.5. Nucleotide Synthesis and Sequencing |
| 12.2.6. Integrated Systems |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Pharmaceuticals & Diagnostics |
| 12.3.2. Chemicals |
| 12.3.3. Biofuels |
| 12.3.4. Bioplastics |
| 12.3.5. Others |
| 12.4. Country Level Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. GCC Countries |
| 12.4.2. South Africa |
| 12.4.3. Rest of MEA |
| 12.5. MEA Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 12.6. MEA Synthetic Biology Market Dynamics – Trends |
| 13. Latin America Synthetic Biology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Core Products |
| 13.1.1.1. Synthetic DNA |
| 13.1.1.2. Synthetic Genes |
| 13.1.1.3. Synthetic Cells |
| 13.1.1.4. Chassis organisms |
| 13.1.1.5. XNO (Xeno Nucleic Acid) |
| 13.1.2. Enabling Products |
| 13.1.2.1. DNA Synthesis |
| 13.1.2.2. Oligonucleotide Synthesis |
| 13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Bioinformatics |
| 13.2.2. Microfluidics |
| 13.2.3. Genetic Engineering |
| 13.2.4. DNA Sequencing |
| 13.2.5. Nucleotide Synthesis and Sequencing |
| 13.2.6. Integrated Systems |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Pharmaceuticals & Diagnostics |
| 13.3.2. Chemicals |
| 13.3.3. Biofuels |
| 13.3.4. Bioplastics |
| 13.3.5. Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Brazil |
| 13.4.2. Mexico |
| 13.4.3. Argentina |
| 13.4.4. Rest of LA |
| 13.5. Latin America Synthetic Biology Market - Opportunity Analysis Index, By Product Type, Technology, Application, 2016-2027 |
| 13.6. Latin America Synthetic Biology Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Thermo Fisher Scientific, Inc. |
| 14.2.2. Genscript |
| 14.2.3. ProteoGenix |
| 14.2.4. OriGene Technologies Inc. |
| 14.2.5. Integrated DNA technologies |
| 14.2.6. Eurofins Scientific, Inc. |
| 14.2.7. Pareto Biotechnologies |
| 14.2.8. Amyris Inc. |
| 14.2.9. TeselaGen |
| 14.2.10. Synthetic Genomics Inc. |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Agilent Technologies (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- GEN9 Inc. (U.S.)
- Novozymes
- Amyris Biotechnologies (U.S.)
- Merck KGaA (Germany)
- Epoch Life Science Inc. (U.S.)
- Intrexon Corporation (U.S.)
- Gevo Inc. (U.S.)
- Gingko Bioworks (U.S)
- Twist Bioscience
- GenScript
- Integrated DNA Technologies, Inc.
- Synthetic Genomics Inc.
- New England Biolabs
- Sangamo Therapeutics, Inc. (U.S.)